Arexis
Latest round
- Series B
Last raised
- Jul 2003
Total raised
- $7.9M
Investors
- 4
About Arexis
Founded in 1999, Arexis AB operates as an integrated pharmaceutical company in Sweden. The company focuses on aspects of inflammation. They were acquired by Biovitrum AB in 2005.
Who invested in Arexis
4 investors across 1 round
See all investors in Arexis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jul 9, 2003
Amount
$7.9M
Investors
Questions about Arexis
Who invested in Arexis?
Arexis has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arexis raised?
Arexis has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Arexis last raise money?
Arexis's most recent round on record is a Series B, in Jul 2003.
What does Arexis do?
Founded in 1999, Arexis AB operates as an integrated pharmaceutical company in Sweden.
Where is Arexis headquartered?
Arexis is headquartered in Gothenburg, Sweden.
Which VCs invest in companies like Arexis?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Arexis's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Arexis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.